Spine Biologics Market - Forecast(2021 - 2026)
Spine Biologics Market Overview Spine Biologics Market size is projected to reach $2,700 million by 2026, growing at a CAGR of 5.9% over 2021-2026. Spinal biologics is a kind of biological material that is used for healing the condition in the spinal. The use of spine biologics becomes an important component in any spinal fusion surgery. Spine biologics helps to provide a mechanism for the growth of bone. The biologics are commonly known as bone graft substitute that helps to improve the growth of new bone. Spine biologics provides a great option for the treatment of degenerative disc disease by reducing chronic back pain. Bone graft is segmented into autograft, allograft, and synthetic grafts which are considered as the most common adjuncts to many orthopedic procedures. Biologics therapies such as platelet-rich plasma represent the beginning of a paradigm shift in orthopedics that helps to avoid aggressive spinal surgery and reduce the need for long-term medications. The biologics ...